Preoperative prediction nomogram based on primary tumor miRNAs signature and clinical-related features for axillary lymph node metastasis in early-stage invasive breast cancer

Diallyl Disulfide Inhibits Breast Cancer Stem Cell Progression and Glucose Metabolism by Targeting CD44/PKM2/AMPK Signaling

(2018) Xinhua Xie et al.   CURRENT CANCER DRUG TARGETS

Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

(2017) Gary H. Lyman et al.   JOURNAL OF CLINICAL ONCOLOGY

PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a

(2017) Xiaojia Huang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

The role of miR-26a and miR-30b in HER2+ breast cancer trastuzumab resistance and regulation of the CCNE2 gene

(2017) Eduardo Tormo et al.   Scientific Reports

Axillary Ultrasound Accurately Excludes Clinically Significant Lymph Node Disease in Patients With Early Stage Breast Cancer

(2016) Natalia S. Tucker et al.   ANNALS OF SURGERY

Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases

(2016) Armando E. Giuliano et al.   ANNALS OF SURGERY

Sentinel Lymph Node Biopsy Versus Axillary Dissection in Node-Negative Early-Stage Breast Cancer: 15-Year Follow-Up Update of a Randomized Clinical Trial

(2016) Giuseppe Canavese et al.   ANNALS OF SURGICAL ONCOLOGY

Long non-coding RNA LINC00161 sensitises osteosarcoma cells to cisplatin-induced apoptosis by regulating the miR-645-IFIT2 axis

(2016) Yuan Wang et al.   CANCER LETTERS

21-Gene Recurrence Score Assay As a Predictor of Adjuvant Chemotherapy Administration for Early-Stage Breast Cancer: An Analysis of Use, Therapeutic Implications, and Disparity Profile

(2016) Jagar Jasem et al.   JOURNAL OF CLINICAL ONCOLOGY

Development and Validation of a Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer

(2016) Yan-qi Huang et al.   JOURNAL OF CLINICAL ONCOLOGY

Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study

(2016) Marina Bagnoli et al.   LANCET ONCOLOGY

De-escalation of axillary surgery in early breast cancer

(2016) Ismail Jatoi et al.   LANCET ONCOLOGY

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

(2016) Fatima Cardoso et al.   NEW ENGLAND JOURNAL OF MEDICINE

A nomogram to predict the probability of axillary lymph node metastasis in early breast cancer patients with positive axillary ultrasound

(2016) Si-Qi Qiu et al.   Scientific Reports

The Role of Mir-148a in Cancer

(2016) Yue Li et al.   Journal of Cancer

Prognostic Value of a BCSC-associated MicroRNA Signature in Hormone Receptor-Positive HER2-Negative Breast Cancer

(2016) Chang Gong et al.   EBioMedicine

Prognostic Nomograms for Prediction of Recurrence and Survival After Curative Liver Resection for Hepatocellular Carcinoma

(2015) Ju Hyun Shim et al.   ANNALS OF SURGERY

EMT in cervical cancer: Its role in tumour progression and response to therapy

(2015) Rehana Qureshi et al.   CANCER LETTERS

Tumour-suppressivemicroRNA-29sdirectly regulateLOXL2expression and inhibit cancer cell migration and invasion in renal cell carcinoma

(2015) Rika Nishikawa et al.   FEBS LETTERS

Development and Validation of a Nomogram for Predicting Survival in Patients With Resected Non–Small-Cell Lung Cancer

(2015) Wenhua Liang et al.   JOURNAL OF CLINICAL ONCOLOGY

A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study

(2015) Xue-Jia Lin et al.   LANCET ONCOLOGY

MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1

(2015) Shichang Deng et al.   Oncotarget

Development of a prediction model for lymph node metastasis in luminal A subtype breast cancer: The possibility to omit sentinel lymph node biopsy

(2014) Chiaki Nakauchi et al.   CANCER LETTERS

A Serum MicroRNA Signature Predicts Tumor Relapse and Survival in Triple-Negative Breast Cancer Patients

(2014) K. Kleivi Sahlberg et al.   CLINICAL CANCER RESEARCH

MicroRNA Biomarkers in Whole Blood for Detection of Pancreatic Cancer

(2014) Nicolai A. Schultz et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

(2014) Gary H. Lyman et al.   JOURNAL OF CLINICAL ONCOLOGY

A Prognostic DNA Methylation Signature for Stage I Non–Small-Cell Lung Cancer

(2013) Juan Sandoval et al.   JOURNAL OF CLINICAL ONCOLOGY

Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs Observation after axillary UltraSouND)

(2012) Oreste Gentilini et al.   BREAST

Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis

(2012) Na Liu et al.   LANCET ONCOLOGY

Trastuzumab Produces Therapeutic Actions by Upregulating miR-26a and miR-30b in Breast Cancer Cells

(2012) Takehiro Ichikawa et al.   PLoS One

Impact of axillary lymph node dissection on breast cancer outcome in clinically node negative patients

(2009) Mona Sanghani et al.   CANCER